All Updates

All Updates

icon
Filter
Funding
Bigtincan secures ~USD 24 million in funding amidst concerns from SQN Investors
Sales Engagement Platforms
Dec 8, 2022
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Sales Engagement Platforms

Sales Engagement Platforms

Dec 8, 2022

Bigtincan secures ~USD 24 million in funding amidst concerns from SQN Investors

Funding

  • Bigtincan, an Australian sales coaching platform, raised AUD 35 million (~USD 23.54 million) in an institutional placement round which consists of 50 million new shares and a share purchase plan that might result in the issuance of up to AUD 10,000 (~USD 6,757) worth of new shares to carry out various mergers and acquisitions.

  • However, SQN, a private equity group that owns 13.6% of the firm that made a takeover bid to Bigtincan earlier this month, deemed this to be "extremely dilutive" and "value-destructive." As a result, SQN's buyout offer of AUD 0.80 per share was reduced by one-fourth at the new shares' AUD 0.60 issue price.

  • According to reports, the group requested Bigtincan to postpone any capital raises or acquisitions for the time being and to uphold its fiduciary duties by having discussions with the parties that have approached the company regarding a control transaction.

  • Analyst QuickTake: SQN’s initial takeover bid, valued Bigtincan at AUD 442 million (~USD 300 million). Despite concerns from shareholders about the best time to pursue strategic changes, the company plans to proceed with its product plan and reportedly found several potential strategic M&A prospects.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.